For the year ending 2025-12-31, EXAS made $3,246,990K in revenue. -$207,949K in net income. Net profit margin of -6.40%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 3,246,990 | |||
| Cost of sales | 984,235 | |||
| Gross profit | 2,262,755 | |||
| Research and development | 522,996 | |||
| Sales and marketing | 1,050,183 | |||
| General and administrative | 888,674 | |||
| Impairment of long-lived and indefinite-lived assets | 7,200 | |||
| Total operating expenses | 2,469,053 | |||
| Other operating income | 0 | |||
| Loss from operations | -206,298 | |||
| Investment income, net | 41,771 | |||
| Interest expense, nonoperating | 39,361 | |||
| Total other income (expense) | 2,410 | |||
| Net loss before tax | -203,888 | |||
| Income tax expense (benefit) | 4,061 | |||
| Net loss | -207,949 | |||
| Increase (decrease) in net loss per share (in usd per share) | -1.1 | |||
| Increase (decrease) in net loss per share (in usd per share) | -1.1 | |||
| Weighted average number of shares outstanding, basic (in shares) | 188,688,000 | |||
| Weighted average number of shares outstanding, diluted (in shares) | 188,688,000 | |||
EXACT SCIENCES CORP (EXAS)
EXACT SCIENCES CORP (EXAS)